Rehman Sana, Nadeem Arsalan, Kasi Arbab Burhan Uddin, Husnain Ali, Waseem Summaiyya, Kumar Sohail, Owais Syed Muhammad, Banu Nasreen, Lakhani Dhairya A, Salim Hamza A, Xu Risheng, Vagal Vaibhav S, Aziz Yasmin N, Hillis Argye E, Urrutia Victor C, Llinas Rafael H, Marsh Elisabeth B, Leigh Richard, Lu Hanzhang, Dmytriw Adam A, Guenego Adrien, Albers Gregory W, Heit Jeremy J, Faizy Tobias D, Yedavalli Vivek S
From the Department of Radiology and Radiological Sciences (S.R., D.A.L., H.A.S., R.X., A.E.H., V.C.U., R.H.L., E.B.M., H.L., G.W.A., V.S.Y.), Johns Hopkins University, Baltimore, Maryland.
Department of Medicine (A.N.), Allama Iqbal Medical College, Lahore, Pakistan.
AJNR Am J Neuroradiol. 2025 Jun 3;46(6):1069-1081. doi: 10.3174/ajnr.A8557.
The hypoperfusion intensity ratio (HIR) is a quantitative metric used in vascular occlusion imaging to evaluate the extent of brain tissue at risk due to hypoperfusion. Defined as the ratio of tissue volume with a time-to-maximum (Tmax) of >10 seconds to that of >6 seconds, HIR assists in differentiating between the salvageable penumbra and the irreversibly injured core infarct. This review explores the role of HIR in assessing clinical outcomes and guiding treatment strategies, including mechanical thrombectomy and thrombolytic therapy, for patients with large-vessel occlusions (LVOs). Evidence suggests that higher HIR values are associated with worse clinical outcomes, indicating more severe tissue damage and reduced potential for salvage through reperfusion. Additionally, HIR demonstrates predictive accuracy regarding infarct growth, collateral flow, and the risk of reperfusion hemorrhage. It has shown superiority over traditional metrics, such as core infarct volume, in predicting functional outcomes. HIR offers valuable insights for risk stratification and treatment planning in patients with LVOs and distal medium vessel occlusions. Incorporating HIR into clinical practice enhances patient care by improving decision-making processes, promoting timely interventions, and optimizing postintervention management to minimize complications and improve recovery outcomes.
低灌注强度比(HIR)是血管闭塞成像中用于评估因低灌注而处于危险中的脑组织范围的定量指标。HIR定义为最大时间(Tmax)>10秒的组织体积与>6秒的组织体积之比,有助于区分可挽救的半暗带和不可逆损伤的核心梗死灶。本综述探讨了HIR在评估大血管闭塞(LVO)患者临床结局和指导治疗策略(包括机械取栓和溶栓治疗)中的作用。证据表明,较高的HIR值与较差的临床结局相关,表明组织损伤更严重,通过再灌注挽救的可能性降低。此外,HIR在梗死灶生长、侧支血流和再灌注出血风险方面具有预测准确性。在预测功能结局方面,它已显示出优于传统指标,如核心梗死灶体积。HIR为LVO和远端中等血管闭塞患者的风险分层和治疗规划提供了有价值的见解。将HIR纳入临床实践可通过改善决策过程、促进及时干预以及优化干预后管理以尽量减少并发症并改善恢复结局来提高患者护理水平。